Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bioventures 2018, L.p. Mpm currently holds 4,318,348 shares of iTeos Therapeutics, Inc. (ITOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bioventures 2018, L.p. Mpm has been a net seller of ITOS stock. They have purchased $2.0M and sold $6.5M worth of shares.
Bioventures 2018, L.p. Mpm's most recent insider trade was on Aug 26, 2026, when they sold 14,569 shares at $7.06 per share.
Bioventures 2018, L.p. Mpm serves as Executive at iTeos Therapeutics, Inc. (ITOS). They have executed 26 insider transactions totaling $8.5M over their tenure at the company.
Bioventures 2018, L.p. Mpm holds the position of Executive at iTeos Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Bioventures 2018, L.p. Mpm has shown a selling trading pattern, with $2.0M in total purchases and $6.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bioventures 2018, L.p. Mpm was on Nov 2, 2021, when they purchased $2.0M worth of TRDA shares. This transaction involved 100,000 shares at $20.00 per share.
Bioventures 2018, L.p. Mpm currently owns 4,318,348 shares of iTeos Therapeutics, Inc. (ITOS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bioventures 2018, L.p. Mpm's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bioventures 2018, L.p. Mpm has 26 Form 4 filings on record as an insider at iTeos Therapeutics, Inc..
Set alerts for Bioventures 2018, L.p. Mpm and 40,000+ other insiders.